MAZZIOTTI, Gherardo
 Distribuzione geografica
Continente #
NA - Nord America 4.193
AS - Asia 1.748
EU - Europa 1.720
SA - Sud America 315
AF - Africa 30
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 8.018
Nazione #
US - Stati Uniti d'America 4.133
CN - Cina 658
SG - Singapore 656
UA - Ucraina 424
PL - Polonia 361
BR - Brasile 276
DE - Germania 265
HK - Hong Kong 175
FI - Finlandia 150
GB - Regno Unito 113
IT - Italia 104
RU - Federazione Russa 78
FR - Francia 71
TR - Turchia 67
IE - Irlanda 64
IN - India 53
VN - Vietnam 53
CA - Canada 36
BD - Bangladesh 21
CZ - Repubblica Ceca 19
SE - Svezia 18
MX - Messico 17
AR - Argentina 16
ZA - Sudafrica 15
NL - Olanda 12
BE - Belgio 10
ES - Italia 10
ID - Indonesia 9
JP - Giappone 9
EU - Europa 7
UZ - Uzbekistan 7
IQ - Iraq 6
IR - Iran 6
CL - Cile 5
SA - Arabia Saudita 5
VE - Venezuela 5
AT - Austria 4
AU - Australia 4
JM - Giamaica 4
MA - Marocco 4
PE - Perù 4
CO - Colombia 3
PK - Pakistan 3
RO - Romania 3
AM - Armenia 2
CH - Svizzera 2
DZ - Algeria 2
EC - Ecuador 2
EG - Egitto 2
GE - Georgia 2
IL - Israele 2
JO - Giordania 2
KE - Kenya 2
KR - Corea 2
LT - Lituania 2
NP - Nepal 2
PA - Panama 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BO - Bolivia 1
BY - Bielorussia 1
CR - Costa Rica 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
KH - Cambogia 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
MU - Mauritius 1
NG - Nigeria 1
NO - Norvegia 1
NR - Nauru 1
PS - Palestinian Territory 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
SR - Suriname 1
TG - Togo 1
TH - Thailandia 1
TN - Tunisia 1
Totale 8.018
Città #
Fairfield 644
Ashburn 424
Warsaw 357
Houston 341
Singapore 319
Woodbridge 316
Jacksonville 290
Seattle 248
Cambridge 234
Ann Arbor 215
Wilmington 199
Beijing 185
Hong Kong 175
Chandler 124
Princeton 118
Nanjing 103
New York 94
Helsinki 79
Los Angeles 71
Dublin 63
Istanbul 57
Nanchang 51
Munich 48
Dallas 47
Moscow 38
Des Moines 34
Shenyang 31
San Diego 30
Brescia 29
Buffalo 26
The Dalles 26
Shanghai 25
San Francisco 23
São Paulo 23
Redondo Beach 22
Chicago 21
Changsha 20
Jiaxing 20
Tianjin 20
Milan 19
Hebei 16
London 16
Washington 16
Mumbai 15
Toronto 15
Boardman 14
Brno 14
Turku 14
Ho Chi Minh City 13
Rio de Janeiro 13
Santa Clara 13
Dong Ket 12
Kunming 12
Poplar 12
Atlanta 11
Denver 11
Hangzhou 11
Manchester 11
Brussels 10
Augusta 9
Brooklyn 9
Tokyo 9
Johannesburg 8
San Mateo 8
Stockholm 8
Cassina de' Pecchi 7
Lancaster 7
Montreal 7
Ankara 6
Belo Horizonte 6
Charlotte 6
Curitiba 6
Dhaka 6
Greifswald 6
Hanoi 6
Jakarta 6
Leawood 6
Orem 6
Brasília 5
Chennai 5
Jinan 5
Mexico City 5
Monmouth Junction 5
Querétaro 5
Tashkent 5
Vancouver 5
Ardabil 4
Bari 4
Boston 4
Calcinate 4
Caracas 4
Council Bluffs 4
Dalmine 4
Dearborn 4
Guangzhou 4
Haikou 4
Kingston 4
Lappeenranta 4
Montes Claros 4
Ningbo 4
Totale 5.686
Nome #
Elevated intraocular pressure in patients with acromegaly 325
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 293
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 172
Morphometric vertebral fractures in breast cancer patients treated with adjuvant aromatase inhibitor therapy: A cross-sectional study 171
Growth hormone deficiency in treated acromegaly 170
Effects of somatostatin analogs on glucose homeostasis: a metaanalysis of acromegaly studies. 167
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors. 158
Development of Graves' hyperthyroidism during the early phase of pregnancy in a patient with pre-existing and long-standing Hashimoto's hypothyroidism. 151
High-dose intramuscular octreotide in patients with acromegaly inadequately controlled on conventional somatostatin analogue therapy: a randomised controlled trial. 146
Vertebral fractures in males with type 2 diabetes treated with rosiglitazone. 140
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 140
MANAGEMENT OF ENDOCRINE DISEASE: Risk of overtreatment in patients with adrenal insufficiency: current and emerging aspects 139
The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly. 133
ASSOCIATION BETWEEN L-THYROXINE TREATMENT, GH DEFICIENCY, AND RADIOLOGICAL VERTEBRAL FRACTURES IN PATIENTS WITH ADULT-ONSET HYPOPITUITARISM. 133
Cardiovascular risk in aging and obesity: is there a role for GH. 133
Effects of lanreotide SR and Autogel on tumor mass in patients with acromegaly: a systematic review. 130
Growth hormone receptor polymorphism and the effects of pegvisomant in acromegaly. 130
Growth hormone deficiency in the adult. 128
VERTEBRAL FRACTURES IN PATIENTS WITH ACROMEGALY: A 3 - YEAR PROSPECTIVE STUDY 126
New understanding and treatments for osteoporosis. 125
Prevalence of vertebral fractures in men with acromegaly 124
Octreotide for acromegaly treatment: a reappraisal. 124
Effect of gonadal status on bone mineral density and radiological spinal deformities in adult patients with growth hormone deficiency. 123
Biochemical evaluation of patients with active acromegaly and type 2 diabetes mellitus: efficacy and safety of the galanin test. 123
Glucocorticoids and the regulation of growth hormone secretion. 123
Recombinant human TSH modulates in vivo C-telopeptides of type-1 collagen and bone alkaline phosphatase, but not osteoprotegerin production in postmenopausal women monitored for differentiated thyroid carcinoma. 123
Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. 117
Increased prevalence of radiological spinal deformities in active acromegaly: a cross-sectional study in postmenopausal women. 116
Serum TSH values and risk of vertebral fractures in euthyroid post-menopausal women with low bone mineral density. 116
Active acromegaly enhances spontaneous parathyroid hormone pulsatility. 114
Vertebral fractures in males with prolactinoma. 113
Cushing's syndrome and bone. 112
Growth hormone replacement therapy and fracture risk 112
Treatment with metformin is protective against limitations in instrumental activities of daily living in older subjects with type 2 diabetes mellitus. 112
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: A multicenter retrospective study 111
Neuroendocrine tumors secreting growth hormone-releasing hormone: Pathophysiological and clinical aspects. 110
Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects. 109
High serum osteoprotegerin levels in patients with hyperthyroidism: effect of medical treatment. 109
Commentary:Postsurgical monitoring of acromegaly 107
Osteoporosis in HIV patients: an emerging clinical issue 107
Pituitary diseases and bone 107
GH deficiency in the adult and bone. 106
Growth hormone, insulin like growth factors, and the skeleton 106
Subclinical thyrotoxicosis and bone 105
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas. 104
Glucocorticoid-induced osteoporosis: pathophysiology and therapy. 103
High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma 103
Meta-analysis on the effects of octreotide on tumor mass in acromegaly. 102
Molecular imaging in acromegaly: should clinicians look carefully at developments in the field? 101
Glucocorticoid-induced osteoporosis: an update. 99
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 98
Long-term effects of the combination of pegvisomant with somatostatin analogs (SSA) on glucose homeostasis in non-diabetic patients with active acromegaly partially resistant to SSA. 98
Prevention and treatment of glucocorticoid-induced osteoporosis. 92
Resistance to somatostatin analogs in acromegaly: an evolving concept? 91
Bone Mineral Density and FRAX Score May Not Predict Fracture Risk in Patients With Cancer Undergoing Hormone Deprivation Therapies 91
Diagnosis and treatment of acromegaly and its complications: consensus guidelines. 90
Glucocorticoid-induced osteoporosis and parathyroid hormone. 89
Drug-induced osteoporosis:mechanism and clinical implications 87
Effect of Degarelix administration on bone health in prostate cancer patients without bone metastases. The Blade study 82
Glucocorticoid replancement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 81
Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome 79
Fat Body Mass and Vertebral Fracture Progression in Women With Breast Cancer 78
Correction: Denosumab improves trabecular bone score in relationship with decrease in fracture risk of women exposed to aromatase inhibitors 74
Bone-active drugs in premenopausal women with breast cancer under hormone-deprivation therapies 68
Growth Hormone Insuline like Growth Factor-1, and the Kidney Pathophysiological and Clinical Implication 60
Prediction of vertebral fractures in cancer patients undergoing hormone deprivation therapies: Reliability of who fracture risk assessment tool (frax) and bone mineral density in real-life clinical practice 60
Real-World Effectiveness of Denosumab and Bisphosphonates on Risk of Vertebral Fractures in Women with Breast Cancer Undergoing Treatment with Aromatase Inhibitors 60
Long-term effects of lanreotide SR and octreotide LAR on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly. 56
Heterogeneity in regional changes in body composition induced by androgen deprivation therapy in prostate cancer patients: potential impact on bone health-the BLADE study 54
Prediction of fragility fractures in men with prostate cancer under androgen deprivation therapy: the importance of a multidisciplinary approach using a mini-invasive diagnostic tool 35
null 13
Totale 8.087
Categoria #
all - tutte 37.161
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.161


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021686 0 0 0 0 0 98 56 107 124 123 150 28
2021/2022511 43 105 10 15 5 25 26 32 23 54 39 134
2022/2023401 69 2 2 22 48 119 1 32 66 2 16 22
2023/2024584 28 14 42 54 42 114 26 17 136 6 6 99
2024/20251.109 6 3 12 156 135 91 58 51 144 43 268 142
2025/20261.327 261 297 144 261 324 40 0 0 0 0 0 0
Totale 8.087